2019 annual financial data
RenovoRx, Inc. 2019 Operating margin
RenovoRx, Inc. 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,896,000 USD and net income was -3,839,000 USD.
Operating cash flow was -3,350,000 USD.
Get free RenovoRx, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,896,000 USD
- Net income
- -3,839,000 USD
- Operating cash flow
- -3,350,000 USD